Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
Applications Due:
Closed
Federal
US Department of Health & Human Services (National Institutes of Health)
This grant provides access to specialized resources and expertise for researchers developing gene-based therapies for extremely rare neurological disorders, helping them prepare for regulatory submissions and advance their therapeutic projects.
Description
The purpose of this FOA is to provide investigators with a mechanism to access contract research/medical organizations (CROs/CMOs) and subject matter experts (SMEs) within the NINDS Ultra-Rare Gene-based Therapy (URGenT) Network to support planning, manufacturing, and limited nonclinical therapeutic development efforts.
Eligibility
States
All
Regions
All
Eligible Entities
State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal organizations, Public housing authorities, Native American tribal organizations, Nonprofits
Funding
Program Funding
Award Ceiling
Award Floor
Award Count
Timing
Posted Date
November 09, 2021
App Status
No Longer Accepting Applications
Pre-app Deadline
December 24, 2024
Application Deadline
December 17, 2024
Funder
Funding Source
Source Type
Federal
Contact Name
NIH OER Webmaster
Contact Email
Contact Phone
--